Your session is about to expire
← Back to Search
Physical Activity Intervention for Cardiovascular Risk
Study Summary
This trial is testing a physical activity intervention to see if it increase cardiovascular disease risk in adults. The intervention includes sessions based on social-cognitive theory, coaching, and a physical activity tracker. The investigators hypothesis that the intervention will be more successful than a control group who just receives a physical activity tracker and information on CDC activity recommendations.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have high blood pressure, high blood sugar, or I am overweight.My BMI is 25 or higher, indicating I am overweight or obese.My doctor agrees I can exercise more on my own.You have been in a program that tracks your physical activity and sets goals in the past year.You do not engage in physical activity for at least 150 minutes per week.I cannot walk or will not be able to walk within the next year.You don't get enough exercise, like walking or playing sports, for at least 150 minutes each week.I am between 40 and 70 years old.I have high blood pressure or I am on medication for it.If I become pregnant, I will get a note from my doctor to continue exercising.I am between 40 and 70 years old.I have been diagnosed with diabetes or cardiovascular disease.My blood sugar or HbA1c levels are high, or I am on medication for it.You can use the internet.
- Group 1: PAT (Physical activity monitor)
- Group 2: ActiveGOALSv2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor presently recruiting participants?
"Clinicaltrials.gov shows that this medical trial is currently recruiting participants, having first been posted on March 29th 2022 and modified as recently as April 8th of the same year."
What beneficial results are expected to be achieved by this clinical trial?
"The primary endpoint of this clinical trial, monitored over a period of 12 months compared to the baseline measurement, is Change from Baseline in Step Counts at 12 Months. Secondary endpoints comprise Blood Pressure taken by clinic staff with an automated cuff after 5 minutes of being seated upright (with three measurements if necessary), Patient Experience Survey created in collaboration with patient partners, and Objectively measured Step Counts via ActiGraph accelerometer."
How many individuals have been recruited to participate in this clinical experiment?
"Affirmative. Clinicaltrials.gov records prove that this medical trial, initially announced on March 29th 2022, is currently seeking participants. Around 54 patients must be enrolled from one distinct medical centre."
Do I fulfill the requirements to join this experiment?
"This research requires 54 participants to meet the criteria of being within the ages 40-70 and having obesity."
Does this research program accept participants aged 75 or above?
"This clinical trial has set 40 years old as the lower limit and 70 years old as the upper boundary for patient recruitment, in accordance with its inclusion criteria."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger